News

The latest SV company and portfolio news.

DDF: Unleashing innovation, a new era for dementia

SV Health Investors Completes Partnership with Packaging Compliance Labs

SV Health Investors Acquires Robling MedicalRead More

EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret™ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema

Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV)

24 January 2023

Britain is losing its chance to become a life sciences superpowerRead More

16 January 2023

British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund

13 December 2022

In its largest single-asset purchase ever, Takeda snaps up TYK2 drug [from SV portfolio company, Nimbus] for $4B upfrontRead More

On heels of Parkinson’s readout, Cerevance enters Alzheimer’s discovery deal with MerckRead More

Kate Bingham interviewed by Beth Rigby, Sky News, on the lessons learnt from the UK Vaccine Taskforce

Fast-track dementia to curb it like CovidRead More

5 December 2021

Kate Bingham FT op-ed: Covid has given UK biotech a lesson — and a legacyRead More

21 October 2021

Xilio Therapeutics Announces Pricing of Initial Public Offering

Kate Bingham is recognised in this year's Queen’s Birthday Honours List

Kate Bingham ranks 18th in Fortune's 'World’s 50 Greatest Leaders'Read More

Houman Ashrafian participated in the Female Founders panel ‘Building a diverse leadership team and board’

Evidation Raises $153M to Scale Virtual Health Capabilities of Achievement™ Platform

Wellspring Capital Management Recapitalizes HealthPRO Heritage

Amathus Therapeutics signs strategic collaboration with Merck to Develop Treatments for Neurodegenerative Diseases

8 February 2021

The Annual Healthcare Growth Update

8 February 2021

Nordic acquires Bails & Associates

3 February 2021

Health Payment Systems, Inc. Welcomes SV Health Investors as New Lead Investor

2 February 2021

AeroCare Announces Completion of Acquisition by AdaptHealth

19 January 2021

Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.

12 January 2021

Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies

11 January 2021

A United Front to Improve Health Outcomes in Northeast Kansas: Healthify's Latest Partnership

Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics

CareSource and Healthify to Address Social Determinants of Health The two organizations will create a statewide accountable social service network.

15 December 2020

SV Health Investors Promotes Greg Madden to Managing Partner

3 December 2020

Merck KGaA and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

1 December 2020

AdaptHealth Corp. Announces Acquisition of National HME Provider AeroCare Holdings Inc. and Updates Financial Guidance For 2021

23 November 2020

Catamaran Bio Launches with $42 Million Financing to Develop Off-the-Shelf CAR-NK Cell Therapies to Treat Solid Tumors

16 November 2020

Centauri Health Solutions Adds Referral Management and Analytics Capabilities with Acquisition of Ivy Ventures, LLC

14 October 2020

Healthify Partners with Altruista Health to Help Payors Address SDoH

PROUD SIGNATORIES

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.